2017 Program Dinner Speakers

Michelle Sholzberg, MDCM, MSc, FRCPC
Dr. Michelle Sholzberg is a clinical hematologist with a focus on bleeding and is the medical director of the coagulation laboratory at St. Michael’s hospital. She is also the co-director of the Hematology-Oncology Clinical Research Group and of the Hematology-Immunology Translational Research Theme. Her research interests include inherited and acquired disorders of hemostasis.

Jeannie Callum, MD, FRCPC, CTBS
Dr. Jeannie L. Callum is the director of Transfusion Medicine and Tissue Banks at Sunnybrook Health Sciences Center in Toronto and associate professor of the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also serves as the sponsor lead for the Ontario Regional Blood Coordinating Network for Central Ontario. Callum’s primary interests in transfusion medicine include error tracking and the management of the coagulopathy associated with traumatic injury and post cardiac surgery.

Yulia Lin, MD, FRCPC, CTBS
Dr. Yulia Lin is a transfusion medicine specialist and hematologist in the Department of Clinical Pathology at Sunnybrook Health Sciences Centre and an Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.

Christopher Patriquin, MD, MSc, FRCPC
Dr. Christopher Patriquin serves as research co-chair of the Canadian PNH Network and is a Canadian national coordinator for the Global PNH Registry. He is also a member of the Canadian Apheresis Group’s TMA working group and lead site editor for www.TalkTMA.com, an online forum focused on education surrounding the thrombotic microangiopathies. In 2016, he joined the University Health Network.

Kevin Kuo, MD, MSc, FRCPC
Dr. Kevin Kuo is a clinician-investigator in the Red Blood Cell Program at Toronto General Hospital, University Health Network. His clinical focus is on rare congenital hemolytic anemias and his research focuses on the impact of white matter changes on neurocognitive outcomes in sickle cell disease, strategies to optimize red blood cell exchange transfusion, genetic modifiers and novel therapies in iron overload and hemoglobinopathies.

Menaka Pai, MD, MSc, FRCPC
Dr. Menaka Pai has been a hematologist and thrombosis medicine physician at the Hamilton General Hospital since 2008. She is currently an Associate Professor in the Department of Medicine, an Associate Member in the Department of Pathology and Molecular Medicine, and Quality Lead for Transfusion Medicine in the Hamilton Regional Laboratory Medicine Program. She is a member of McMaster University’s Thrombosis and Atherosclerosis Research Institute and the McMaster Centre for Transfusion Research.

Donald M. Arnold, MDCM, MSc, FRCPC
Dr. Donald Arnold is the Director of the McMaster Centre for Transfusion Research and the John G. Kelton Chair in Translational Research. Dr. Arnold’s research interests are in immunemediated platelet disorders and optimal utilization of blood transfusions. He is the lead investigator on several multicentre clinical trials in immune thrombocytopenia (ITP) and has developed a translational research program on the pathophysiology of ITP funded by the Canadian Institutes of Health Research and Canadian Blood Services and the McMaster Centre for Transfusion Research.